---
title: COPD
layout: diseases
author: Corbin Cox
last-updated: 2018-12-22
created: 2018-12-22
toc: true
common: false
---

# Dx[^goldCOPD]

* COPD Defined as FEV<sub>1</sub>/FVC &le; 0.7
* Other respiratory SSx are cause for suspicion, but not diagnostic
* Screen for &alpha;-1 antitrypsin deficiency

## Classification

**All staging must be done when stable. Pts cannot be staged during an exacerbation**

GOLD (Spirometric) Assessment
{: .caption}

| GOLD Stage | Severity    | FEV<sub>1</sub> Criteria |
| ---------- | ----------- | ------------------------ |
| 1          | Mild        | &ge; 80%                 |
| 2          | Moderate    | [50%,80)                 |
| 3          | Severe      | [30%,50%)                |
| 4          | Very Severe | &lt; 30%                 |

Symptomatic Assessment
{: .caption}

| mMRC Grade | SSx Description                                          |
| ---------- | -------------------------------------------------------- |
| 0          | SOB w/ strenuous exercise                                |
| 1          | SOB when hurrying or going uphill                        |
| 2          | Stop for breath at own pace, must walk slower than other |
| 3          | Unable to walk 100m w/o SOB                              |
| 4          | Cannot leave house or easily dress self w/o SOB          |

Group Assignment
{: .caption}

<table>
  <tr>
    <td>&ge; 2 exacerbations <br /> or <br />&ge; 1 hospitalization</td>
    <td>C</td>
    <td>D</td>
  </tr>
  <tr>
  	<td>&le; 1 exacerbation <br />No hospitalization</td>
    <td>A</td>
    <td>B</td>
  </tr>
  <tr>
  	<td></td>
    <td>mMRC &le; 1 <br />CAT &lt; 10</td>
    <td>mMRC &ge; 2 <br />CAT &ge; 10</td>
  </tr>
</table>


# Outpatient Tx[^goldCOPD]

* Smoking Cessation
* Vaccination
  * Influenza
  * Consider PPSV23 in pts &lt; 65 with comorbidities or with FEV<sub>1</sub> &lt; 40%
* Everyone gets a SABA inhaler
* Can add supplemental O2 as needed, target O2sat &ge; 90%
* 

## Group A

1. Bronchodilator
2. Try different bronchodilator

## Group B

1. LABA or LAMA
2. LAMA + LABA

## Group C

1. LAMA
2. LAMA + LABA (preferred) or LABA + ICS

## Group D

1. LAMA
2. LAMA + LABA or LABA + ICS or LAMA + LABA + ICS
   * Preferred to try LAMA + LABA then LAMA + LABA + ICS
3. Add Roflumilast if continued exacerbations, FEV<sub>1</sub> &lt; 50%
4. Consider macrolide Abx in former smokers

# Exacerbation Tx[^goldCOPD]<sup>, </sup>[^tintinalli]

## Classification

* **No respiratory Failure:** RR 20-30 BPM, no accessory muscle use, improves w/ supplemental O2, no increase in PaCO2, and no changes in mental status
* **Non-life Threatening Acute Respiratory Failure:** Hypercarbia 50-60, accessory muscle use, no mental status changes
* **Life Threatening Acute Respiratory Failure:** Mental status changes, hypercabia &gt; 60, acidosis

## Tx

* Give Non-invasive ventilation for respiratory compromise
* Add / increase bronchodilators (SABA or SABA + SABA appropriate)
  * Consider Epinephrine 0.3-0.5mg SubQ Q20min x3 doses or Terbutaline 0.25mg SubQ Q20min x3 doses if not responding to or tolerating inhaled bronchodilators
* Consider GCs
  * Prednisone 40-60mg Q4-6H or equivalent
  * Methylprednisolone 1mg/kg IV is a good parenteral choice
  * Usually 5-7d course
* Consider 5-7d of Abx
  * Usually Azithromycin 500mg on day 1 then 250mg QD x4d[^lexi]
  * Can consider doxycycline or Amox or Augmentin
  * Coverage of Strep pneumoniae, H. influenzae, and Moraxella catarrhalis 

# References
{% include sources.md %}